GP2 Values
GP2 Visits India
Learn MoreGP2 recently visited India where study team members took advantage of the 8th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC) he…
Precision Medicine in Parkinson’s Disease: Past Lessons and New Frontiers
Learn MoreMembers of the GP2 Trainee Network recently had the opportunity to attend a two-day conference called ‘Precision Medicine in Parkinson's Disease: past lessons …
The Components of GP2’s Fourth Data Release
Learn MoreIn February 2023, GP2 announced the fourth data release on the Terra platform in collaboration with AMP® PD. This release is packed full of new data and resour…
International Day of Women and Girls in Science
Learn MoreTo celebrate International Day of Women and Girls in Science, representatives of the GP2 Trainee Network have written a post honoring the women in roles as lea…
Introducing the GP2 Trainee Representatives
Learn MoreThis blog talks about how the GP2 Trainee Representatives have emerged as a meaningful role within the GP2 Trainee Network to mediate communication between GP2…
Diversity in Parkinson’s Disease Genetics Research
Learn MoreThis blog talks about the reasons the study about PD genetics among non European populations was carried out and how GP2 intends to learn from it to minimize h…
Impressions of GP2 AIM from the GP2 Trainees’ Perspective
Learn MoreThis year, the first ever GP2 Annual Investigators Meeting (AIM) was held in Madrid. This blog contains insights and impressions from members of the GP2 Traine…
GP2 Celebrates the International Day of Women and Girls in Science
Learn MoreOn the International Day of Women and Girls in Science, Sara Bandres-Ciga, Co-lead Training, Networking and Communication working group, shares how GP2 is work…
Overcoming Challenges to Black and African American Representation in Parkinson’s Research
Learn MoreTo address the challenge of recruiting Black and African American individuals into BLAAC PD, GP2 researchers have developed an innovative two-pronged approach:…
Understanding Genetic Implications of the Black and African American Connections to Parkinson’s Disease Study (BLAAC PD)
Learn MoreOver the last two decades, we have witnessed a revolution in the research area of complex genetic diseases, including Parkinson’s disease. Great advances have …
GP2 and AMP PD: Platform Partners for Progress in Parkinson’s Research
Learn MoreAdding a layer of compute to connect two massive datasets is where we are headed. Mike Nalls, Hampton Leonard, Matt Bookman, and Eline Appelmans outline the pa…
Open Science Opens Doors
Learn MoreIn GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to ac…
A letter to the patient community from Randy Schekman, ASAP Scientific Director
Learn MoreASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, sha…
A Blueprint for Training and Development in GP2
Learn MoreTraining is a crucial element of GP2. In this blog post, Alastair Noyce, Sara Bandres-Ciga and Emily Fisher outline the program's training and development goal…
Why study disease in different populations?
Learn MoreGP2 aims to revolutionize our understanding of the genetics of Parkinson's disease across populations. Ignacio 'Nacho' Mata explains the importance of involvin…
